These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10624114)
21. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Cho Mar K; Eimoto T; Nagaya S; Tateyama H Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928 [TBL] [Abstract][Full Text] [Related]
22. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [TBL] [Abstract][Full Text] [Related]
23. [Significance of argyrophilic proteins of the nucleolar organizer region in differentiation of benign and malignant growth of thyroid epithelial tumors]. Bukaeva IA; Smirnova EA; Pavlovskaia AI; Makanin MA; Ol'khovskaia IG; Raĭkhlin NT Arkh Patol; 2001; 63(3):15-8. PubMed ID: 11452646 [TBL] [Abstract][Full Text] [Related]
24. [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid]. Snarska J; Szajda SD; Knaś M; Mroczko B; Borzym-Kluczyk M; Kamiński F; Zwierz P; Zwierz K Wiad Lek; 2006; 59(5-6):332-5. PubMed ID: 17017477 [TBL] [Abstract][Full Text] [Related]
25. [Nodular goiter and thyroid cancer]. Valdina EA Vestn Khir Im I I Grek; 1997; 156(2):23-6. PubMed ID: 9235760 [TBL] [Abstract][Full Text] [Related]
26. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid. Nasir A; Catalano E; Calafati S; Cantor A; Kaiser HE; Coppola D In Vivo; 2004; 18(2):189-95. PubMed ID: 15113046 [TBL] [Abstract][Full Text] [Related]
27. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Galgano MT; Mills SE; Stelow EB Am J Surg Pathol; 2006 Oct; 30(10):1269-73. PubMed ID: 17001158 [TBL] [Abstract][Full Text] [Related]
28. Hyalinizing trabecular adenoma of the thyroid gland--a report of two cases. Lewy-Trenda I; Wierzchniewska-Lawska A Pol J Pathol; 1999; 50(4):301-3. PubMed ID: 10721271 [TBL] [Abstract][Full Text] [Related]
29. Clinical value of calcifications in thyroid carcinoma and multinodular goiter. Consorti F; Anello A; Benvenuti C; Boncompagni A; Giovannone G; Moles N; Scardella L; Antonaci A Anticancer Res; 2003; 23(3C):3089-92. PubMed ID: 12926167 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874 [TBL] [Abstract][Full Text] [Related]
32. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions. Mehrotra A; Goel MM; Singh K Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321 [TBL] [Abstract][Full Text] [Related]
33. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression. Slowińska-Klencka D; Klencki M; Popowicz B; Sporny S; Lewiński A Histol Histopathol; 2004 Jul; 19(3):785-92. PubMed ID: 15168341 [TBL] [Abstract][Full Text] [Related]
34. Ag-NOR counting for differentiation of follicular thyroid tumours. Cör A; Pajer Z Pathologica; 1994 Jun; 86(3):301-3. PubMed ID: 7808803 [TBL] [Abstract][Full Text] [Related]
35. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland. Zaczek M; Szot W; Chłap Z Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102 [TBL] [Abstract][Full Text] [Related]
36. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions. Słowińska-Klencka D; Klencki M; Popowicz B; Lewiński A Anal Quant Cytol Histol; 2003 Dec; 25(6):347-52. PubMed ID: 14714301 [TBL] [Abstract][Full Text] [Related]
37. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042 [TBL] [Abstract][Full Text] [Related]
38. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250 [TBL] [Abstract][Full Text] [Related]
39. Comparison of metallothionein (MT) and Ki-67 antigen expression in benign and malignant thyroid tumours. Królicka A; Kobierzycki C; Puła B; Podhorska-Okołów M; Piotrowska A; Rzeszutko M; Rzeszutko W; Rabczyński J; Domosławski P; Wojtczak B; Dawiskiba J; Dzięgiel P Anticancer Res; 2010 Dec; 30(12):4945-9. PubMed ID: 21187474 [TBL] [Abstract][Full Text] [Related]
40. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]